Piramal Pharma Limited (BOM:543635)

Market Cap	277.15B
Revenue (ttm)	89.49B
Net Income (ttm)	389.00M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	712.46
Forward PE	n/a
Dividend	0.11 (0.05%)
Ex-Dividend Date	n/a

Volume	410,055
Average Volume	350,441
Open	217.65
Previous Close	218.05
Day's Range	206.60 - 222.65
52-Week Range	114.45 - 307.85
Beta	n/a
RSI	44.45
Earnings Date	May 9, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 6,719
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635